GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children: A Randomized, Controlled, Pilot Study.
Phase of Trial: Phase II
Latest Information Update: 26 Oct 2012
At a glance
- Drugs Exenatide (Primary)
- Indications Glucose intolerance; Obesity
- Focus Therapeutic Use
- 10 Nov 2011 Results published in Obesity.
- 28 Jun 2011 Interim results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 27 Sep 2010 Trial phase changed from IV to II as reported by ClinicalTrials.gov.